logo
Plus   Neg
Share
Email

JPMorgan Q2 Profit Up 16%, Results Beat Estimates

JPMorgan Chase & Co. (JPM) reported a profit for the second quarter that increased 16 percent from last year, driven by its diversified global business model and an income tax benefit related to the resolution of certain tax audits. Both earnings per share and revenue for the quarter beat analysts' expectations.

Net income for the second quarter grew 16 percent to $9.65 billion from last year's $8.32 billion, with earnings per share increasing to $2.82 from $2.29 in the prior year.

On average, 23 analysts polled by Thomson Reuters expected the company to report earnings of $2.50 per share for the quarter. Analysts' estimates typically exclude special items.

The provision for credit losses was $1.15 billion, down from $1.21 million in the prior year.

Total net revenue rose to $28.8 billion from $27.8 billion in the prior-year quarter. On a Managed Basis, net revenue was $29.57 billion, up 4 percent from $28.39 billion in the previous year. Wall Street expected revenues of $28.91 billion for the quarter.

Net interest income was $14.5 billion, up 7 percent, driven by balance sheet growth and mix, as well as the impact of higher rates. Non-interest revenue was $15. 0 billion, up 2 percent from last year.

Noninterest expense was $16.3 billion, up 2 percent, driven by continued investments in the business and higher auto lease depreciation, partially offset by lower FDIC charges.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Polaris Industries Inc. is recalling certain Ranger and General Utility, as well as All-Terrain vehicles citing risks of crash, the U.S. Consumer Product Safety Commission said in a statement. The Medina, Minnesota-based company has called back about 26,730 units of Model Year 2019 - 2020 Ranger XP 1000 & Model Year 2020 General XP 1000 Utility vehicles. Gilead Sciences Inc. (GILD) said Friday that the European Commission has granted conditional marketing authorization for Veklury or remdesivir as a treatment for SARS-CoV-2 infection, the virus that causes COVID-19. FedEx is asking NFL team Washington Redskins to change its name for its racist connotations. The delivery services company, which is a major sponsor for the team, made the suggestion following increasing pressure from its investors amid the ongoing protests against racial injustice and inequality that arose from the killing of African-American George Floyd.
Follow RTT